These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 16883107
1. [Right and wrong of salmeterol/fluticasone propionate combination]. Sagara H. Arerugi; 2006 Jul; 55(7):794-810. PubMed ID: 16883107 [Abstract] [Full Text] [Related]
2. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients. Adachi M, Aizawa H, Ishihara K, Ohta K, Sano Y, Taniguchi H, Nakashima M. Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875 [Abstract] [Full Text] [Related]
3. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P. Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683 [Abstract] [Full Text] [Related]
4. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients]. Miyagawa T. Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508 [Abstract] [Full Text] [Related]
5. Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD. Cazzola M, Noschese P, Centanni S, Santus P, Di Marco F, Spicuzza L, Di Maria GU. Pulm Pharmacol Ther; 2004 Nov; 17(3):141-5. PubMed ID: 15123223 [Abstract] [Full Text] [Related]
6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [Abstract] [Full Text] [Related]
7. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma. Delea TE, Hagiwara M, Stempel DA, Stanford RH. Allergy Asthma Proc; 2010 Jul; 31(3):211-8. PubMed ID: 20615321 [Abstract] [Full Text] [Related]
8. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma. Li HT, Zhang TT, Zhou H, Qu XJ, Wu WM, Huang J. Respiration; 2007 Jul; 74(1):33-43. PubMed ID: 17008769 [Abstract] [Full Text] [Related]
9. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. Jarjour NN, Wilson SJ, Koenig SM, Laviolette M, Moore WC, Davis WB, Doherty DE, Hamid Q, Israel E, Kavuru MS, Ramsdell JW, Tashkin DP, Reilly DS, Yancey SW, Edwards LD, Stauffer JL, Dorinsky PM, Djukanovic R. J Allergy Clin Immunol; 2006 Jul; 118(1):44-52. PubMed ID: 16815137 [Abstract] [Full Text] [Related]
10. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Delea TE, Hagiwara M, Stanford RH, Stempel DA. Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796 [Abstract] [Full Text] [Related]
12. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N. J Asthma; 2007 Dec; 44(6):437-41. PubMed ID: 17654129 [Abstract] [Full Text] [Related]
13. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily. Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM. Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361 [Abstract] [Full Text] [Related]
14. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation]. Wettengel R, Steinkamp G. Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652 [No Abstract] [Full Text] [Related]
15. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. Pedersen SE, Bateman ED, Bousquet J, Busse WW, Yoxall S, Clark TJ, Gaining Optimal Asthma controL Steering Committee and Investigators. J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765 [Abstract] [Full Text] [Related]
16. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down". Koenig SM, Ostrom N, Pearlman D, Waitkus-Edwards K, Yancey S, Prillaman BA, Dorinsky P. J Asthma; 2008 Oct; 45(8):681-7. PubMed ID: 18951261 [Abstract] [Full Text] [Related]
17. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Pediatr Pulmonol; 2009 May; 44(5):429-35. PubMed ID: 19382218 [Abstract] [Full Text] [Related]
18. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ. COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [Abstract] [Full Text] [Related]
20. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P. Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]